
Axsome Therapeutics
AXSM
|
NASDAQ
|
9 Followers
Fair Price

$712.69
Undervalued by 57.8%
To display the fair price of a share, you need to be a member of Bulios Black.
Company Quality
Profitability Score
17/100
Solvency Score
45/100
Dividends
Dividends data currently unavailable.Earnings
8/4/2025
in 50 days
$140M
Revenue est.
-1.00
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Biotechnology
Industry
Dr. Herriot Tabuteau M.D.
CEO
712
Employees
New York City
Headquarters
US
Country
Key Metrics TTM
Valuation
Market cap.
$5.1BEnterprise Value
$5BPrice to Earnings
-18.28Price to Sales
11.86Price to Book
95.62Price to Cash Flow
-43.34Profitability
Return on Assets
-46.64%Return on Equity
-363.79%Return on Invested Capital
-76.54%Gross Margin
91.49%Operating Margin
-62.54%Net Margin
-64.39%Liquidity
Quick Ratio
1.96Current Ratio
2.03Cash Ratio
1.23Inventory Turnover
2.25Asset Turnover
0.72Total Liabilities
$543MSolvency
Debt to Assets
0.35Debt to Equity
N/AInterest Coverage
-34.66Equity Ratio
0.09Long-term Debt to Cap.
0.80Altman Z-Score
2.52Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.